Aldrich M.B.,University of Texas Health Science Center at Houston |
Guilliod R.,Memorial Hermann Center for Wound Healing |
Fife C.E.,Memorial Hermann Center for Wound Healing |
Maus E.A.,Memorial Hermann Center for Wound Healing |
And 3 more authors.
Biomedical Optics Express
Current treatment of unilateral breast cancer-related lymphedema (BCRL) is only directed to the afflicted arm. Near-infrared fluorescent imaging (NIRF) of arm lymphatic vessel architecture and function in BCRL and control subjects revealed a trend of increased lymphatic abnormalities in both the afflicted and unafflicted arms with increasing time after lymphedema onset. These pilot results show that BCRL may progress to affect the clinically "normal" arm, and suggest that cancer-related lymphedema may become a systemic, rather than local, malady. These findings support further study to understand the etiology of cancer-related lymphedema and lead to better diagnostics and therapeutics directed to the systemic lymphatic system. © 2012 Optical Society of America. Source